Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection

References

• Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979–88.
   PubMed Web of Science ®Google Scholar
• Gilkin RJ Jr. The spectrum of irritable bowel syndrome: a clinical review. Clin Ther 2005;27:1696–709.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578–83.
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605–11.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651–9.
   PubMed Web of Science ®Google Scholar
• Thornley JP, Jenkins D, Neal K, Wright T, Brough J, Spiller RC. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001;184:606–9.
   PubMed Web of Science ®Google Scholar
• Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007;56:1066–71.
   PubMed Web of Science ®Google Scholar
• Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 2011;23:e479–88.
   PubMed Web of Science ®Google Scholar
• Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002;51:410–13.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhea. Lancet 1996;347:150–3.
   PubMed Web of Science ®Google Scholar
• Zhang L, Budiman V, Day AS, Mitchell H, Lemberg DA, Riordan SM, et al. Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol 2010;48:2965–7.
   PubMed Web of Science ®Google Scholar
• Kaakoush NO, Mitchell HM. Campylobacter concisus - A new player in intestinal disease. Front Cell Infect Microbiol 2012;2:4.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Günzel D, Zeitz M, et al. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. PLoS One 2011;6:e23858.
   PubMed Web of Science ®Google Scholar
• Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 2010;202:1855–65.
   PubMed Web of Science ®Google Scholar
• Kalischuk LD, Inglis GD. Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans. BMC Microbiol 2011;11:53.
   PubMedGoogle Scholar
• Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, et al. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012;7:e38217.
   PubMedGoogle Scholar
• Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, Dutt S, et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 2009;47:453–5.
   PubMed Web of Science ®Google Scholar
• Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One 2011;6:e21490.
   PubMed Web of Science ®Google Scholar
• Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, et al. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 2011;6:e25417.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Ejlertsen T, Engberg J, Nielsen H. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect 2013;19:445–50.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Engberg J, Ejlertsen T, Bücker R, Nielsen H. Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect 2012;18:E459–65.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 2013;32:1194–8.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702–6.
   PubMed Web of Science ®Google Scholar
• Tornblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007;5:461–4.
   PubMedGoogle Scholar
• Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci 2006;51:1026–32.
   PubMed Web of Science ®Google Scholar
• Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997;314:779–82.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis. Scand J Gastroenterol 2013;48:633–5.
   PubMed Web of Science ®Google Scholar
• Sorensen NB, Nielsen HL, Varming K, Nielsen H. Neutrophil activation by Campylobacter concisus. Gut Pathog 2013;5:17.
   PubMedGoogle Scholar
• Moss-Morris R, Spence M. To “lump” or to “split” the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med 2006;68:463–9.
   PubMed Web of Science ®Google Scholar
• Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006;43:898–901.
   PubMedGoogle Scholar
• Barbara G, Stanghellini V, Berti-Ceroni C, De Giorgio R, Salvioli B, Corradi F, et al. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment Pharmacol Ther 2000;14:1127–31.
   PubMed Web of Science ®Google Scholar